One-year Cardiac Follow-up of Patients With COVID-19 Pneumonia
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 380
- 试验地点
- 2
- 主要终点
- Echocardiographic assessment of cardiac function
研究概览
简要总结
The primary objective of the study is to assess the cardiac status of COVID-19 pneumonia patients during 1 year after discharge
详细描述
Although COVID-19 manifests in most cases with respiratory symptoms, cardiovascular abnormalities is common in hospitalized patients. Patients with cardiovascular risk factors or established disease appear to have a worse prognosis. Myocardial dysfunction could be a direct manifestation of COVID-19. The investigators hypothesize that subjects after COVID-19 pneumonia present myocardial and vascular remodeling during 1 year after discharge, even in the absence of prior cardiovascular disease.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with documented COVID-19 pneumonia
排除标准
- •Patients with cancer
- •Impossible to follow up
结局指标
主要结局
Echocardiographic assessment of cardiac function
时间窗: up to one year
Echocardiographic assessment of global strain parameters at 3 and 12 months after discharge
次要结局
- Quantitative analysis of parenchymal lung damage(up to one year)
- Evaluation of coagulation abnormality(up to one year)
- Evaluation of quality of life in first year after discharge(up to one year)
- МАССЕ(up to one year)
- Evaluation of renal function(up to one year)
- Functional exercises capacity assessment(up to one year)
- Evaluation of inflammation(up to one year)